Did Pfizer's Obesity Shot Do Well Enough To Catch Lilly? - Investor's Business Daily
An analyst says Eli Lilly's Zepbound still looks like the heavyweight in obesity.
Search Group
Share To
Comments
About Screade
Screade® Inc. version f068cd5, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments